Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
OR52A5 and sickle cell disease are reported together in 2 articles.
Gene
OR52A5
- HGNC
- HGNC:19580
2articles
2mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Sickle cell disease
- HPO
- HP:0001878
- OMIM
- 603903
828articles
828mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
2 records shown · first 60Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients.
PMID 41409427 | PMCID PMC12705626 | DOI 10.3389/fbinf.2025.1671626 · Frontiers in bioinformatics · 2025 · 9 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | OR52A5 | “Furthermore, novel drug targets encoded by olfactory receptor (OR) gene clusters (OR51V1, OR52A1, OR52A5, OR51B5, and OR51S1), TRIM genes, SIDT2, and CADM3 displayed high druggability scores.” | 0.98 | hgnc_dict_v1 |
| phenotype | sickle cell disease | “Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | OR51V1 | “Furthermore, novel drug targets encoded by olfactory receptor (OR) gene clusters (OR51V1, OR52A1, OR52A5, OR51B5, and OR51S1), TRIM genes, SIDT2, and CADM3 displayed high druggability scores.” | 0.98 | hgnc_dict_v1 |
| gene | OR52A1 | “Furthermore, novel drug targets encoded by olfactory receptor (OR) gene clusters (OR51V1, OR52A1, OR52A5, OR51B5, and OR51S1), TRIM genes, SIDT2, and CADM3 displayed high druggability scores.” | 0.98 | hgnc_dict_v1 |
Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease.
PMID 37895268 | PMCID PMC10606407 | DOI 10.3390/genes14101919 · Genes · 2023 · 31 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | OR52A5 | “Seven of the identified variants are located in olfactory receptor family 51 genes (OR51B5, OR51V1, OR51A1P, and OR51E2), and five variants were related to family 52 genes (OR52A5, OR52K1, OR52K2, and OR52T1P).” | 0.98 | hgnc_dict_v1 |
| phenotype | sickle cell disease | “Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | MTHFR | “A number of candidate polymorphisms in certain genes (e.g., FVL, PRT, and MTHFR) were previously reported as risk factors for TEEs in different clinical conditions.” | 0.98 | hgnc_dict_v1 |
| gene | OR51B5 | “Seven of the identified variants are located in olfactory receptor family 51 genes (OR51B5, OR51V1, OR51A1P, and OR51E2), and five variants were related to family 52 genes (OR52A5, OR52K1, OR52K2, and OR52T1P).” | 0.98 | hgnc_dict_v1 |